Skip to main content
Caplight Logo









CTI Life Sciences Fund

CTI Life Sciences Fund

Overview

CTI Life Sciences Fund is a knowledge-driven boutique venture capital firm that aims to deliver strong results on investments in Life Sciences . Their mission is to catalyze emerging science, transform business objectives, and invest in scalable companies within Canada, the United States and Europe . They focus on pre-clinical and early clinical-stage therapeutics companies, with a secondary focus on mid-and growth-stage medtech opportunities and an exploratory focus on Healthcare Services and Healthcare IT .

Year Founded

2006

Portfolio Companies

13

Investments

CTI Life Sciences Fund investments
CompanyDateStageLead
Topadur Pharma AGApr 2016GrantCo-investor
Ability PharmaceuticalsMar 2024Early FundingLead
DalCor PharmaceuticalsSep 2023Series DCo-investor
Thryv TherapeuticsNov 2026Series BCo-investor
Eulitha AGApr 2012GrantCo-investor
Book a demo to see all 13 portfolio companies

For institutional investors. Book with your work email.

Key People

Laurence Rulleau

Managing Partner At CTI LSF III

Youssef Bennani

Managing Partner-CTI Life Sciences

Xin Hang

Principal

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is CTI Life Sciences Fund based?

CTI Life Sciences Fund is headquartered in Quebec.

When was CTI Life Sciences Fund founded?

CTI Life Sciences Fund was founded in 2006.

How many portfolio companies does CTI Life Sciences Fund have?

CTI Life Sciences Fund has 13 portfolio companies in Caplight's dataset.

What are some companies in CTI Life Sciences Fund's portfolio?

Portfolio companies visible on Caplight include Topadur Pharma AG, Ability Pharmaceuticals, DalCor Pharmaceuticals, Thryv Therapeutics, Eulitha AG.

What was CTI Life Sciences Fund's most recent investment shown here?

CTI Life Sciences Fund's most recent investment in this portfolio sample was in Thryv Therapeutics in 2026.

What sectors does CTI Life Sciences Fund focus on?

CTI Life Sciences Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.

What company stages does CTI Life Sciences Fund focus on?

CTI Life Sciences Fund typically invests at the MultiStage stage.

What is CTI Life Sciences Fund's AUM?

CTI Life Sciences Fund's assets under management are estimated between $250.0M and $500.0M.

Firmographic Details

HeadquartersQuebec
Year Founded2006

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?